ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 832

Factors That Affect Tender and Swollen Joint Counts In Rheumatoid Arthritis

Christine L. Amity1, Marisa Eckels2, Kenneth N. Gold3, Kelly A. Reckley4, Niveditha Mohan5, Stephen R. Wisniewski6, Elizabeth A. Schlenk7, Marc C. Levesque8,9 and Terence W. Starz10, 1Rheumatology & Clinical Immun, Univ of Pittsburgh, Pittsburgh, PA, 2Arthritis and Internal Medicine Associates, University of Pittsburgh Medical Center, Pittsburgh, PA, 3Arthritis & Internal Medicine, Pittsburgh, PA, 4Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 5Div of Rheum & Clin Immunol, Univ of Pittsburgh Arth Inst, Pittsburgh, PA, 6Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, 7School of Nursing, University of Pittsburgh, Pittsburgh, PA, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh Department of Medicine, Pittsburgh, PA, 9Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 10Arth & Internal Med Associates, Pittsburgh, PA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: assessment and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: ARHP Noteworthy Abstracts

Session Type: Abstract Submissions (ARHP)

Background/Purpose: Quantitative joint counts are used to determine rheumatoid arthritis (RA) disease activity and are increasingly important for routine clinical practice to optimize patient care.  Several factors make quantitative joint assessments challenging.  The purpose of this study was to determine how osteoarthritis (OA), fibromyalgia (FM), body mass index (BMI), handedness and disease activity affect tender and swollen joint counts by examining their effects on the inter-rater reliability of tender and swollen joint counts in a usual care setting.

Methods: 72 RA patients (54 F, 18M) recruited from the University of Pittsburgh Rheumatoid Arthritis Comparative Effectiveness Research (RACER) registry underwent standardized 28-joint assessments performed by two registered nurses and two rheumatologists at a single clinic visit.  A Manual Tender Point (TP) Survey to determine the presence of FM (≥ 11/18 TPs) took place during the same visit. Hand X-rays within 1 year of the clinic visit were graded for the presence of OA by a blinded, independent rheumatologist.  BMI and disease duration were obtained from registry data.  Subjects were classified according to Clinical Disease Activity Index (CDAI) as being in remission-low (CDAI ≤ 10) or moderate-high (CDAI > 10) disease activity. Intra-class correlations and 95% CIs were determined for tender and swollen joints, stratified by variables of interest.

Results: The overall agreement among raters was moderate for tender and swollen joints (ICC = 0.48 and ICC = 0.56, respectively).  The agreement among raters for swollen joints was similar in subjects with and without OA, with disease duration < or ≥ 3 years, with BMI < or ≥ 30 and with remission-low or moderate-high disease activity (ICC = 0.17 to 0.56).  For tender joints, agreement was also moderate between disease duration and BMI subgroups (ICC = 0.47 to 0.64).  However there were significant differences in agreement for tender joints for subjects with OA versus without (ICC = 0.33 (0.12, 0.50) vs. ICC = 0.65 (0.55, 0.72), respectively), and for subjects in remission-low disease activity versus moderate-high (ICC = 0.13 (-0.03, 0.29) vs. ICC = 0.52 (0.39, 0.63), respectively).

Conclusion: Agreement between raters was only moderate for tender and swollen joint counts.  The presence of OA and lower disease activity reduced inter-rater reliability significantly.  These results indicate that new methods of assessing joint disease activity may be needed for many of the patients seen in usual care settings as opposed to clinical trials where subjects are generally younger, have less OA and higher levels of disease activity.  Our future analyses will focus on the level of agreement between nurses and physicians, on the level of agreement at the individual joint level, and on multivariable analyses that incorporate all factors that may affect inter-rater agreement of tender and swollen joint counts.


Disclosure:

C. L. Amity,

Genentech and Biogen IDEC Inc.,

2;

M. Eckels,
None;

K. N. Gold,
None;

K. A. Reckley,

Genentech and Biogen IDEC Inc.,

2;

N. Mohan,
None;

S. R. Wisniewski,
None;

E. A. Schlenk,
None;

M. C. Levesque,

Genentech and Biogen IDEC Inc.,

2,

Genentech and Biogen IDEC Inc.,

5;

T. W. Starz,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-that-affect-tender-and-swollen-joint-counts-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology